MENU
Developing a cat probiotic? Explore strain selection, EU authorisation, viable counts, manufacturing and shelf-life testing of the finished feed product.
Developing a cat probiotic does not end with choosing a microorganism supported by a scientific paper. A brand also needs a legally suitable ingredient source, an appropriate process and evidence that the finished product maintains the required parameters during storage. These stages answer different questions.
Run three assessments in parallel: nutritional rationale, permitted use and technical feasibility. Their combination provides the basis for a complementary compound feed formula.
A species name does not fully identify the material investigated in a study. Establish the strain designation, preparation characteristics, study population, amount and administration period. These details determine the paper's relevance to the intended product.
An example is the study of Enterococcus faecium SF68 in shelter cats and dogs. It concerns a particular strain and setting rather than all products described as probiotics. Findings should not automatically be transferred to another strain, a multi-ingredient blend or a different intended use.
Adding more microorganisms does not replace that analysis. Each additional component creates further questions about identity, compatibility and quality control.
A microorganism used as a feed additive requires verification of the relevant authorisation. Regulation (EC) No 1831/2003 provides the framework, while the European Commission's feed additives page gives access to the register and authorisation legislation.
Assessment should cover additive identity, target species, conditions of use, declarations and any restrictions associated with the authorisation holder. Check the current act applicable to the particular preparation; a supplier catalogue name is insufficient.
SF68 is mentioned here as an example of interpreting research, not as a purchasing recommendation or confirmation of the current status of every similarly named product. Conduct the legal assessment for the actual material before including it in the formula.
Colony-forming units, or CFU, describe an enumeration result obtained using a specified method. A raw material result does not automatically represent the finished blend.
Distinguish specification requirements for incoming material, product batch release and the end of stated shelf life. Then define how compliance will be demonstrated. Any technological overage should be evidence-based and remain within legal conditions of use; it cannot substitute for solving instability.
Consider this development example: a supplier reports a satisfactory result for a sealed raw material sample, but the finished product will use a multidose pack opened daily. The raw material documentation does not establish the behaviour of that new matrix and pack. Data for the final configuration are required.
Developing a feline product containing microorganisms? Contact team@foodup.com.pl. FoodUP helps connect documentation assessment, formulation and finished-product testing.
Prototype work should assess processing, moisture, temperature and storage. Other formula components should not be assumed to have no effect on the microorganisms. Compatibility requires evaluation in the actual blend.
Define the stage at which the preparation is added, blending conditions, homogeneity and sampling. Assess product acceptance and complete serving consumption separately. A stable product left in the bowl does not meet its use assumptions.
Organise quality control within Regulation (EC) No 183/2005. Selection of an enumeration method and laboratory should account for the particular microorganism and finished-product matrix.
Assess claims under Article 13 of Regulation (EC) No 767/2009. A publication investigating disease does not permit an ordinary feed blend to be presented as treating it.
For each message, identify the evidence, its connection with the formula and the limits of interpretation. Our discussion of pet food claims provides a useful starting point. Marketing substantiation and the specification must describe the same product version.
Not on that basis alone. Verify its status and conditions of use for feline nutrition.
No. The count must be interpreted against the strain, evidence, intended purpose and authorisation conditions.
No. The final blend, process, packaging and shelf life also require assessment.
Findings should not automatically be transferred between species. Relevance requires justification and limitations must be stated.
European Commission: feed additives and access to the EU register.
Checklists of health labels and claims — how not to waste weeks on corrections
